Critical Path Institute’s Patient-Reported Outcome (PRO) Consortium: A Translatability Assessment Context
C-Path’s PKDOC Presentation on Fluid-Based Biomarkers Critical Path Institute’s John-Michael Sauer, Ph.D. presents information on fluid-based biomarkers and how they can be applied
C-Path Forms Data Collaboration with International Niemann-Pick Disease Registry (INPDR) to Propel Niemann-Pick Disease Research Forward TUCSON, Ariz. April 17, 2024 — Critical Path Institute (C-Path), a leader in advancing rare disease research, today announced a
Practical considerations for the use of clinical outcome assessments (COAs) in pediatric clinical research with examples from pediatric gastroenterology